– UK, London – Spire Healthcare Group plc (LON: SPI), a leading UK independent hospital group, today announced the appointment of Sir Ian Cheshire to its Board as Chairman-designate effective on 4 March 2021, succeeding Garry Watts who will retire as Chairman following the AGM on 13 May 2021.
About Sir Ian Cheshire
Sir Ian brings to Spire Healthcare considerable FTSE experience, a deep understanding of the government-business interface, and broad ESG credentials
Sir Ian’s long and distinguished career included 17 years at Kingfisher plc, the last seven of which was as Group CEO. He was also CEO of B&Q. Sir Ian offers significant chair experience having most recently served as Chairman of Barclays UK for four years during which time he helped establish the ring-fenced bank and successfully set up its board and governance structure. Sir Ian has held several Lead Non-Executive roles in the UK Government, including Lead Non-Executive Member of the Cabinet Office Board. Sir Ian also has considerable ESG credentials through prominent roles such as Chairman of The Prince of Wales Corporate Leaders Group on climate change and president of the Business Disability Forum President’s Group.
Sir Ian Cheshire commented: “I am delighted to join Spire Healthcare at such an important time for UK healthcare. The company has navigated the challenges of COVID-19 well and is set to emerge from the pandemic with a stronger business. I look forward to helping the management team to drive that business forward.”
Sir Ian Cheshire is currently a non-executive director of both Barclays Bank plc and BT Group plc and chairman of Menhaden plc. He served as a chairman of Debenhams plc until January 2019.
About Spire Healthcare
Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and 8 clinics across England, Wales, and Scotland.
Working in partnership with around 7,300 experienced consultants, Spire Healthcare delivered tailored, personalized care to approximately 810,000 in-patients and daycase patients in 2019, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.
The Group’s well located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance providers. 90% of Spire Healthcare’s hospitals are rated ‘Good’ or ‘Outstanding’ by the CQC (or the equivalent in Scotland and Wales).
Spire Healthcare treats patients through a variety of routes including PMI, Self-pay, and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with a longer life expectancy
For more information : https://www.spirehealthcare.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
